Sebia, a global specialty diagnostic company, develops, manufactures and commercializes IVD tests and analyzers dedicated to the in vitro diagnosis of cancer, inflammatory diseases, diabetes and hemoglobin disorders. Sebia's focus on electrophoresis techniques enables it to maintain a sustained R&D program, providing access to genuine innovations in any lab. Both agarose gel and capillary assays, and their dedicated automation, are designed to be integrated into the same routine workflow; for gel (Assist, Hydrasys 2 Scan) and for capillary electrophoresis (Capillarys 3 TERA, stand alone or in work cell configuration up to three instruments with tube loader, Capillarys 2 Flex Piercing, Minicap Flex Piercing).
View Top Employees from SEBIA IncWebsite | http://www.sebia.com |
Revenue | $45 million |
Employees | View employees |
Address | 1705 Corporate Dr, Ste 400, Norcross, Georgia 30093, US |
Phone | (770) 446-3707 |
Fax | (678) 807-2900 |
Industry | Medical Devices & Equipment, Manufacturing |
Competitors | Carolina Liquid Chemistries Corp., Clinical Diagnostic Solutions, Diatron Medical Instruments, Eiken Chemical Co Ltd, Helena Laboratories Italia Spa |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular SEBIA Inc employee's phone or email?
The SEBIA Inc annual revenue was $45 million in 2023.
SEBIA Inc is based in Norcross, Georgia.
The NAICS codes for SEBIA Inc are [33, 339].
The SIC codes for SEBIA Inc are [384, 38].